China Money Network
Login
Join

Shanghai Pharmaceuticals, Primavera’s $239M Buyout Of Australia’s Vitaco Gets FIRB Approval

  • October 24, 2016 — 13:53 CST

This Data Is Locked!

This area is available only to Subscribers.

A US$239 million deal led by Chinese drugmaker Shanghai Pharmaceuticals Holding Co., Ltd. and private equity firm Primavera Capital to acquire Australian vitamins maker Vitaco... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: